Treatment of severe neuroleptic-induced tardive torticollis

Annals of General Psychiatry

Volumn 2, Issue , 2003, Pages

  Havaki Kontaxaki, Beata J ^a   Kontaxakis, Vassilis P ^a   Margariti, Maria M ^a   Paplos, Konstantinos G ^a   Christodoulou, George N ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Botulinum toxin A; Clonazepam; Clozapine; Neuroleptics; Tardive torticollis

Indexed keywords

BIPERIDEN; BOTULINUM TOXIN A; CLONAZEPAM; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; TRIFLUOPERAZINE; ZUCLOPENTHIXOL;

ADULT; ARTICLE; CASE REPORT; CLINICAL TRIAL; DELUSIONAL DISORDER; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSTONIA; HUMAN; LONG TERM CARE; MALE; MENTAL DISEASE; MONOTHERAPY; NECK PAIN; NEUROLEPTIC INDUCED TARDIVE TORTICOLLIS; PHYSICAL DISABILITY; RATING SCALE; REMISSION; SHOULDER; TORTICOLLIS; TREATMENT OUTCOME;

EID: 21244456890     PISSN: 1744859X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1475-2832-2-9     Document Type: Article

References (23)

1. Van Harten PN and Kahn RS: Tardive dystonia. Schizophrenia Bull 1999, 25:741-748.
2. Kiriakakis V, Bhatia KP and Marsden CD: The natural history of tardive dystonia: A long-term follow up of 107 cases. Brain 1998, 121:2053-2066.
3. Adityanjee, Adezibijde YA, Jampala C and Mathews T: The current status of tardive dystonia. Biol Psychiatry 1999, 45:715-730.
4. Burke RE, Fahn S, Jankovic J, Marsden CD, Lang AE, Gollomp S and Ilson J: Tardive dystonia : Late onset and persistent dystonia caused by antipsychoyic drugs. Neurology 1982, 32:1335-1346.
5. Tsui JKC, Eisen A, Stoessl AJ, Calne S and Calne DB: Duble-blind study of botulinum toxin in spasmodic torticollis. Lancet 1986, 2:245-246.
6. Overall JE and Gohram DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962, 10:799-812.
7. Caine E, Polinsky R, Kartzinel R and Ebert M: Trial use of clozapine for abnormal movement disorders. Am J Psychiatry 1979, 136:317-320.
8. Lieberman J, Saltz B, John C, Pollak S, Borenstein M and Kane J: The effect of clozapine in tardive dyskinesia. Br J Psychiatry 1991, 154:503-510.
9. Adityanjee and Estrera AB: Successful treatment of tardive dystonia with clozapine. Biol Psychiatry 1996, 39:1064-1065.
10. Lamberti JS and Bellnier T: Clozapine and tardive dystonia. J Nerv Ment Dis 1993, 181:137-138.
11. Van Harten PN, Kamphuis DJ and Matroos GE: Use of clozapine in tardive dystonia. Prog Neuro-Psychopharmacol & Biol Psychiatry 1996, 20:263-274.
12. Freedman J: Clozapine treatment of psychosis in patients with tardive dystonia. Mov Disorders 1994, 9:321-324.
13. Trugman JM, Leadbetter R and Zalis ME: Treatment of several axial tardive dystonia with clozapine: case report and hypothesis. Mov Disorders 1994, 9:441-446.
14. Black LM, Marks RC, Nierman P and Luchins DJ: Clozapine and clonazepam in tardive dystonia. J Clin Psychopharmcol 1991, 11:268-269.
15. Shapleske J, Mckay AP and Makenna PJ: Successful treatment of tardive dystonia with clozapine and clonazepam. Br J Psychiatry 1996, 168:516-518.
16. Littrell KH, Johnson CG, Littrell S and Peabody CD: Marked reduction of tardive dyskinesia with olanzapine. Arch Gen Psychiatry 1998, 55:279-280.
17. Jaffe ME and Simpson GM: Reduction of tardive dystonia with olanzapine. Am J Psychiatry 1999, 156:2016.
18. Fukui H and Murai T: Marked improvement of Meige's Syndrome with olanzapine in a schizophrenic patient. J Neuropsychiatry Clin Neurosci 2002, 14:355-356.
19. Moore P: Handbook of Botulinum Toxin Treatment. Cambridge, England: Blakwell Science Ltd; 1995.
20. Tsuong D, Hermanowicz N and Rontal M: Botulinum toxin in treatment of tardive dyskinetic syndrome. J Clin Psychopharmacol 1990, 6:438-439.
21. Kaufman DM: Use of botulinum injections for spasmodic torticollis of tardive dystonia. J Neurochem Clin Neurosciences 1994, 6:50-53.
22. Chatterjee A, Forrest GM, Giladi N and Trosh R: Botulinum toxin in the treatment of tardive dystonia. J Clin Psychopharmacol 1997, 17:497-498.
23. Tarsy D, Kaufman D, Sehti KD, Rivner ME, Molho E and Factor S: An open-label study of botulinum toxin A for treatment of tardive dystonia. Clin Neuropharmacol 1997, 20:90-93.